A new study published in HSR, an official journal of AcademyHealth, found that while the use of new cancer therapies did result in noteworthy improvements in lung cancer survival rates, Medicare spending increased substantially, raising concerns about the financial burden of these treatments.
A report from the National Academy of Medicine (NAM) found that a lack of trust was a key barrier to data sharing. Expert panelists from Cincinnati Children’s Hospital, the National Partnership for Women and Families, PCORI, and the NAM delved into this topic at the recent Health Datapalooza and National Health Policy Conference.
Informed by discussant interviews, this report highlights themes in successful state-based maternal health data linkage initiatives, gaps in implementing such initiatives, and the status of current data linkages to address maternal mortality and severe maternal morbidity.
Members of AcademyHealth’s Child Health Services Research Interest Group Advisory Committee reflect on five key areas of advancement of Child HSR during 2020, and consider the COVID-19 pandemic’s impact on children.
In a JAMA commentary published last week, three Medicaid Medical Directors from AcademyHealth’s Medicaid Medical Directors Network examine how Medicaid programs can ensure equitable administration of COVID-19 vaccines.
The severity and the complexity of the opioid crisis require research that is both patient-centered and supported by robust data infrastructure. Several U.S. Department of Health and Human Services (HHS) projects are working across agencies to build the nation’s capacity for exactly this kind of research.
Research by an AcademyHealth member considers how substance use disorder (SUD) treatment facilities can operationalize each of eight person-centered care dimensions using the experiences and perspectives of treatment providers, administrators, and clients.
Climate change and the COVID-19 pandemic both have profound negative impacts on our health, wellbeing, and way of life, and exacerbate health inequities. Both threats also call for collaboration on an unprecedented scale and speed.
A recent discussion, focused on ensuring sufficient investment and interest in vaccine development for the next infectious threat, brought to light the incredible complexity involved in developing, manufacturing and distributing a vaccine on a massive scale in an equitable way.